carbamazepine has been researched along with betadex in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewster, ME; Düsing, R; Hönack, D; Löscher, W; Richter, A; Schulz, HU; Schürer, M | 1 |
| Hönack, D; Löscher, W | 1 |
| Anderson, WR; Bodor, N; Brewster, ME; Cheung, B; Derendorf, H; Estes, KS; Meinsma, D; Moreno, D; Pablo, L; Pop, E; Sawchuk, R; Webb, AI | 1 |
| Izzo, G; Kenndler, E; Maichel, B; Raggi, MA | 1 |
| Bassani, VL; Koester, LS; Mayorga, P; Xavier, CR | 1 |
| Bassani, VL; Koester, LS; Mayorga, P | 1 |
| Bassani, VL; Koester, LS; Mayorga, P; Pereira, VP; Petzhold, CL | 1 |
| Chang, RK; Shojaei, AH | 1 |
| Bassani, VL; Bertuol, JB; Dalla Costa, T; Groch, KR; Koester, LS; Mayorga, P; Moellerke, R; Xavier, CR | 1 |
| Bassani, VL; Koester, LS; Mayorga, P; Ortega, GG | 1 |
| Macrae, RJ; Smith, JS; Snowden, MJ | 1 |
| Ao, X; Stenken, JA | 1 |
| Chotai, NP; Patel, MP; Patel, NV | 1 |
| de Araújo, BV; Kelmann, RG; Koester, LS; Kratz, JM; Kuminek, G; Ribeiro, R; Simões, CM; Teixeira, HF | 1 |
| Prabhu, AA; Rajendiran, N; Venkatesh, G | 1 |
| Scriba, GK; Wongwan, S | 1 |
| Cai, C; Kou, W; Liu, J; Wang, H; Xu, S; Yang, D; Zhang, T | 1 |
| Coutinho, EC; Date, AA; Jain, AS; Nagarsenker, MS; Pissurlenkar, RR | 1 |
| Dahan, A; Miller, JM | 1 |
| Djurić, Z; Ibrić, S; Kachrimanis, K; Medarević, D | 1 |
20 other study(ies) available for carbamazepine and betadex
| Article | Year |
|---|---|
New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Carbamazepine; Chemistry, Pharmaceutical; Cyclodextrins; Dogs; Drug Evaluation, Preclinical; Injections, Intravenous; Male; Polyethylene Glycols; Solutions; Solvents | 1995 |
Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Carbamazepine; Cyclodextrins; Disease Models, Animal; Drug Administration Schedule; Electroshock; Humans; Injections, Intravenous; Male; Mice; Pharmaceutical Vehicles; Polyethylene Glycols; Rats; Solutions; Solvents; Status Epilepticus | 1997 |
Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Anticonvulsants; beta-Cyclodextrins; Biological Availability; Carbamazepine; Cross-Over Studies; Cyclodextrins; Dogs; Infusions, Intravenous; Suspensions; Tablets | 1997 |
Separation of olanzapine, carbamazepine and their main metabolites by capillary electrophoresis with pseudo-stationary phases.
Topics: Antipsychotic Agents; Benzodiazepines; beta-Cyclodextrins; Carbamazepine; Cyclodextrins; Electrophoresis, Capillary; Olanzapine; Pirenzepine | 2001 |
Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
Topics: Anticonvulsants; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbamazepine; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclodextrins; Excipients; Hypromellose Derivatives; Methylcellulose; Microscopy, Electron, Scanning; Solubility; Spectrophotometry, Infrared; Tablets | 2003 |
Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile.
Topics: Anticonvulsants; beta-Cyclodextrins; Carbamazepine; Chemistry, Pharmaceutical; Cyclodextrins; Dosage Forms; Drug Compounding; Excipients; Hypromellose Derivatives; Methylcellulose; Solubility; Technology, Pharmaceutical; Time Factors | 2003 |
Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
Topics: Anticonvulsants; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbamazepine; Chemistry, Pharmaceutical; Cyclodextrins; Dosage Forms; Drug Compounding; Excipients; Hypromellose Derivatives; Methylcellulose; Microscopy, Electron, Scanning; Spectrophotometry, Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2003 |
Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbamazepine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cyclodextrins; Drug Compounding; Excipients; Mass Spectrometry; Propylene Glycol; Solubility; Water | 2004 |
Bioavailability of carbamazepine:beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets.
Topics: Animals; beta-Cyclodextrins; Biological Availability; Carbamazepine; Chemistry, Pharmaceutical; Dogs; Drug Evaluation, Preclinical; Female; Hypromellose Derivatives; Methylcellulose; Tablets | 2004 |
Mathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to beta-cyclodextrin.
Topics: beta-Cyclodextrins; Carbamazepine; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Hypromellose Derivatives; Methylcellulose; Models, Theoretical; Tablets, Enteric-Coated | 2004 |
Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
Topics: Algorithms; beta-Cyclodextrins; Carbamazepine; Chemistry, Pharmaceutical; Delayed-Action Preparations; Excipients; Hydrogen-Ion Concentration; Hypromellose Derivatives; Methylcellulose; Povidone; Solubility; Spectrophotometry, Ultraviolet | 2005 |
No delayed temporal response to sample concentration changes during enhanced microdialysis sampling using cyclodextrins and antibody-immobilized microspheres.
Topics: Animals; beta-Cyclodextrins; Carbamazepine; Cytokines; Mice; Microdialysis; Microspheres; Time Factors | 2006 |
Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
Topics: Algorithms; Anticonvulsants; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbamazepine; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Hardness; Microscopy, Electron, Scanning; Oxcarbazepine; Solubility; Tablets; X-Ray Diffraction | 2008 |
Pharmacokinetic study of a carbamazepine nanoemulsion in beagle dogs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anticonvulsants; beta-Cyclodextrins; Carbamazepine; Cross-Over Studies; Dogs; Emulsions; Excipients; Female; Injections, Intravenous; Nanoparticles; Random Allocation | 2009 |
Unusual spectral shifts of imipramine and carbamazepine drugs.
Topics: beta-Cyclodextrins; Carbamazepine; Hydrogen Bonding; Imipramine; Models, Molecular; Molecular Structure; Reference Standards; Solvents; Spectrometry, Fluorescence; Viscosity | 2010 |
Impurity profiling of dexamphetamine sulfate by cyclodextrin-modified microemulsion electrokinetic chromatography.
Topics: Amphetamine; beta-Cyclodextrins; Carbamazepine; Chromatography, Micellar Electrokinetic Capillary; Dextroamphetamine; Drug Contamination; Emulsions; Linear Models; Reproducibility of Results; Stereoisomerism | 2010 |
In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Anticonvulsants; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Carbamazepine; Chromatography, Liquid; Dogs; Excipients; Female; Hypromellose Derivatives; Methylcellulose; Solubility; Tablets; Tandem Mass Spectrometry; Time Factors; X-Ray Diffraction | 2011 |
Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
Topics: Administration, Oral; Animals; Anticonvulsants; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbamazepine; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Compounding; Epilepsy; Magnetic Resonance Spectroscopy; Mice; Microscopy, Electron, Scanning; Models, Molecular; Pentylenetetrazole; Solubility; Spectrophotometry, Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; beta-Cyclodextrins; Carbamazepine; Chemistry, Pharmaceutical; Excipients; Hydrocortisone; Intestinal Absorption; Models, Chemical; Permeability; Progesterone; Reproducibility of Results; Solubility; Technology, Pharmaceutical | 2012 |
Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbamazepine; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Models, Molecular; Polyethylene Glycols; Polyvinyls; Solubility | 2015 |